Biju; Purakkattle
Patent Applications and Registrations
Patent applications and USPTO patent grants for Biju; Purakkattle.The latest application filed is for "novel substituted n'-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase (ido) inhibitors".
- Biju; Purakkattle - Westwood MA
- Biju; Purakkattle - Piscataway NJ
- BIJU; Purakkattle - Boston MA US
| Patent | Date |
|---|---|
| Substituted n'-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors Grant 10,988,487 - Liu , et al. April 27, 2 | 2021-04-27 |
| Novel Substituted N'-hydroxycarbamimidoyl-1,2,5-oxadiazole Compounds As Indoleamine 2,3-dioxygenase (ido) Inhibitors App 20200231606 - Liu; Kun ; et al. | 2020-07-23 |
| Compounds as indoleamine 2,3-dioxygenase inhibitors Grant 10,538,497 - Han , et al. Ja | 2020-01-21 |
| Antidiabetic tricyclic compounds Grant 10,519,115 - Biftu , et al. Dec | 2019-12-31 |
| Tricyclic compounds as inhibitors of mutant IDH enzymes Grant 10,442,819 - Fischer , et al. Oc | 2019-10-15 |
| Tricyclic compounds as inhibitors of mutant IDH enzymes Grant 10,399,972 - Witter , et al. Sep | 2019-09-03 |
| Novel Compounds As Indoleamine 2,3-dioxygenase Inhibitors App 20180362482 - Han; Yongxin ; et al. | 2018-12-20 |
| Aminoquinazoline compounds as A.sub.2A antagonist Grant 10,138,212 - Ali , et al. Nov | 2018-11-27 |
| Antidiabetic tricyclic compounds Grant 10,000,454 - Biftu , et al. June 19, 2 | 2018-06-19 |
| Antidiabetic tricyclic compounds Grant 9,932,311 - Biftu , et al. April 3, 2 | 2018-04-03 |
| Aminoquinazoline Compounds As A2a Antagonist App 20180037554 - Ali; Amjad ; et al. | 2018-02-08 |
| Antidiabetic substituted heteroaryl compounds Grant 9,834,563 - Hagmann , et al. December 5, 2 | 2017-12-05 |
| Antidiabetic Substituted Heteroaryl Compounds App 20170166578 - Hagmann; William K. ; et al. | 2017-06-15 |
| Antidiabetic Tricyclic Compounds App 20170081287 - Biftu; Tesfaye ; et al. | 2017-03-23 |
| Antidiabetic tricyclic compounds Grant 9,527,875 - Hagmann , et al. December 27, 2 | 2016-12-27 |
| Antidiabetic Tricyclic Compounds App 20160257652 - Biftu; Tesfaye ; et al. | 2016-09-08 |
| Antidiabetic Tricyclic Compounds App 20160207887 - Biftu; Tesfaye ; et al. | 2016-07-21 |
| Antidiabetic Tricyclic Compounds App 20150191495 - Hagmann; William K. ; et al. | 2015-07-09 |
| Antidiabetic Tricyclic Compounds App 20140045746 - Hagmann; William K. ; et al. | 2014-02-13 |
| ALPHA2C adrenoreceptor agonists Grant 7,985,748 - McCormick , et al. July 26, 2 | 2011-07-26 |
| Alpha2c Adrenoreceptor Agonists App 20100173823 - McCormick; Kevin D. ; et al. | 2010-07-08 |
| Phenoxypiperidines and analogs thereof useful as histamine H.sub.3 antagonists Grant 7,638,531 - Mutahi , et al. December 29, 2 | 2009-12-29 |
| Phenoxypiperidines and analogs thereof useful as histamine H3 antagonists App 20070167435 - Mutahi; Mwangi W. ; et al. | 2007-07-19 |
| Alpha2C adrenoreceptor agonists App 20070093477 - McCormick; Kevin D. ; et al. | 2007-04-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 